Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry."

Chronology Information

Date:

Chapter/issue
Pharmaceutical Companies
Key Person(s)
Dr Steven J Ojala